TrialFrontiers in immunology2023

Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden.

Per Eriksson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.